Ivy Science Financials
| ISTNX Fund | USD 67.09 1.47 2.24% |
Ivy |
Please note that past performance is not an indicator of the future performance of Ivy Science, its manager's success, or the effectiveness of its strategy. The performance results shown here may have been adversely or favorably impacted by events and economic conditions that may not prevail in the future. Therefore, you must use caution to infer that these results indicate any fund, manager, or strategy's future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Ivy Science Fund Summary
Ivy Science competes with VivoPower International, Exela Technologies, Wetouch Technology, Ivy Large, and Ivy Small. The fund invests primarily in the equity securities of science and technology companies around the globe. Under normal circumstances, it invests at least 80 percent of its net assets in securities of science or technology companies. The fund also may invest in companies that utilize science andor technology as an agent of change to significantly enhance their business opportunities. It may invest in securities issued by companies of any size, and may invest without limitation in foreign securities, including securities of issuers within emerging markets. The fund is non-diversified.Specialization | Technology, Large Growth |
| Instrument | USA Mutual Fund View All |
| Exchange | NMFQS Exchange |
| ISIN | US46600A7404 |
| Business Address | Ivy Funds |
| Mutual Fund Family | Ivy Funds |
| Mutual Fund Category | Technology |
| Benchmark | NYSE Composite |
| Phone | 800 777 6472 |
| Currency | USD - US Dollar |
Ivy Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ivy Science's current stock value. Our valuation model uses many indicators to compare Ivy Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ivy Science competition to find correlations between indicators driving Ivy Science's intrinsic value. More Info.Ivy Science And is currently considered the top fund in price to earning among similar funds. It is currently considered the top fund in price to book among similar funds fabricating about 0.10 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Ivy Science And is roughly 10.07 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ivy Science by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ivy Science's Mutual Fund. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ivy Science's earnings, one of the primary drivers of an investment's value.Ivy Science And Systematic Risk
Ivy Science's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ivy Science volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Ivy Science And correlated with the market. If Beta is less than 0 Ivy Science generally moves in the opposite direction as compared to the market. If Ivy Science Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ivy Science And is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ivy Science is generally in the same direction as the market. If Beta > 1 Ivy Science moves generally in the same direction as, but more than the movement of the benchmark.
Ivy Science April 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ivy Science help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ivy Science And. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ivy Science And based on widely used predictive technical indicators. In general, we focus on analyzing Ivy Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ivy Science's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.53 | |||
| Information Ratio | (0.0003) | |||
| Maximum Drawdown | 8.32 | |||
| Value At Risk | (2.22) | |||
| Potential Upside | 2.21 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ivy Science And. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.